National Account Director
Boost your chances before you apply.
UroGen Pharma, Inc
US
Summary
The National Account Director develops and executes strategic market access plans for enterprise payer and healthcare accounts to optimize coverage and patient access. They serve as a subject matter expert, providing strategic guidance to cross-functional teams and maintaining executive relationships with key healthcare decision-makers.
Job Description
About the Company
UroGen is a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers. We are fundamentally changing the way patients are treated for urologic cancers.
Watch our New Horizons in Bladder Cancer event and discover why it’s an exciting time to join UroGen® Pharma. Join us and be part of the team that will redefine the future of urological cancer treatment. Behind every UroGen innovation is the inspiration to empower uro-oncology patients with life-changing treatments.
At UroGen, our people are our greatest asset. We cultivate a culture built on collaboration, creativity, and continuous growth. UroGen is a dynamic, rapidly expanding organization with an unwavering focus on improving the lives of patients because they deserve better
Job Summary
The National Account Director (NAD) serves as the strategic market access leader for assigned enterprise payer and healthcare organization accounts, responsible for developing and executing access strategies that optimize coverage, medical policy, and patient access for UroGen therapies. The NAD establishes and maintains executive relationships with national, regional, government, and integrated healthcare organizations while proactively influencing coverage and reimbursement policies. In partnership with Field Reimbursement Managers (FRMs), Key Account Directors (KADs), and Regional Business Directors (RBDs), the NAD serves as the market access subject matter expert, providing strategic support on complex coverage, prior authorization, coding, reimbursement, and payment issues. The role also monitors payer trends and communicates actionable insights that help regional teams identify opportunities and address evolving market access challenges.
Supervisory Responsibilities:
- Indirectly supervises employees through a matrix structure and influences cross-functional teams.
Experience
- Minimum 15 years of Pharmaceutical/Biotech experience, including 10+ years in Market Access and Managed Markets.
- Proven relationships with government and commercial payers, integrated delivery systems, professional organizations, and state societies.
- Current in-depth knowledge of Medicare Part B, Medicare Advantage, CMS regulations, specialty distribution, managed care trends, and Part B reimbursement.
- Strong strategic thinking, analytical, problem-solving, and business acumen.
- Ability to thrive in a fast-paced entrepreneurial biotechnology environment.
- Excellent verbal, written, and presentation skills.
Education
- BA/BS required; MBA or other advanced degree preferred.
- Develop and execute enterprise account strategies that optimize coverage, medical policy, and patient access across assigned national, government, regional, and integrated healthcare organization accounts.
- Identify, develop, and execute business opportunities by focusing on appropriate value-based relationships within key targeted payer and healthcare organization accounts.
- Demonstrate expertise in payment reform, reimbursement policy, and evolving payment models.
- Monitor and interpret Medicare, commercial, and integrated delivery system coverage policies, identifying trends and communicating strategic insights to Commercial and Market Access leadership.
- Establish executive relationships with government and commercial health plans, plan medical directors, pharmacy directors, and key decision makers influencing coverage or medical policies.
- Execute enterprise market access strategies within assigned accounts while partnering with regional field teams to ensure consistent execution and customer support.
- Lead or participate in strategic Market Access projects and cross-functional initiatives that support organizational priorities, contributing beyond assigned account responsibilities in a collaborative, entrepreneurial environment
- Educate and support Regional Business Directors, Key Account Directors, and Field Reimbursement Managers on payer coverage policies, reimbursement trends, and market access opportunities impacting regional performance.
- Serve as the market access subject matter expert for Regional Business Directors and their teams by providing strategic guidance on complex coverage, prior authorization, coding, reimbursement, and payment issues.
- Identify and communicate distribution and product access issues or trends to impacted field teams and cross-functional partners.
- Provide coverage and market access updates at regional and national meetings.
- Provide payer perspective and strategic input to distributors, contractors, managed markets, medical, marketing, and brand teams as needed.
- Understand the implications of payer and government regulatory decisions and proactively develop strategies and solutions.
- Approximately 75% travel required.
We offer a competitive salary, employee benefits, and an excellent work environment.
- Medical
- Dental
- Vision
- 401k Match
- Paid Time Off
- Employee Assistance Program
UroGen Pharma is a biotech company that builds novel solutions to revolutionize the way specialty cancers and urologic diseases are treated – because patients deserve better options. Our vision is grounded in our RTGel® drug delivery technology, our promising pipeline, and a collaborative drive for bold results.
Our existing technology: the RTGel drug delivery technology has the potential to be applied to a variety of unmet medical needs. RTGel reverse-thermal hydrogel is liquid at lower temperatures and converts to gel form at body temperature, offering the opportunity to make local therapy a more effective treatment.
Our promising pipeline: Ranging from pre-clinical to Phase 3, we currently have multiple candidates in our pipeline, which are furthering the study of potential treatment advances in urology, uro-oncology, and immunology.
Our collaborative drive: We are part of a broad ecosystem of partners who are seeking to improve patient care; these connections are vital to our commitment to offer new pathways and advance solutions. We are continually evaluating new partnership opportunities.
Founded
2004
Company size
51-200 employees
Industry
Biotechnology Research
Org type
Public Company
Headquarters
Princeton, New Jersey
UroGen Pharma is a biotech company that builds novel solutions to revolutionize the way specialty cancers and urologic diseases are treated – because patients deserve better options. Our vision is grounded in our RTGel® drug delivery technology, our promising pipeline, and a collaborative drive for bold results.
Our existing technology: the RTGel drug delivery technology has the potential to be applied to a variety of unmet medical needs. RTGel reverse-thermal hydrogel is liquid at lower temperatures and converts to gel form at body temperature, offering the opportunity to make local therapy a more effective treatment.
Our promising pipeline: Ranging from pre-clinical to Phase 3, we currently have multiple candidates in our pipeline, which are furthering the study of potential treatment advances in urology, uro-oncology, and immunology.
Our collaborative drive: We are part of a broad ecosystem of partners who are seeking to improve patient care; these connections are vital to our commitment to offer new pathways and advance solutions. We are continually evaluating new partnership opportunities.
Founded
2004
Company size
51-200 employees
Industry
Biotechnology Research
Org type
Public Company
Headquarters
Princeton, New Jersey